Viatris Inc (VTRS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Viatris Inc Stock (VTRS) Company Profile

Healthcare (1155)

(724) 514-1465

1000 MYLAN BOULEVARD, CANONSBURG

Nächster Verdiensttermin

Neueste SEC-Einreichungen

VTRS's Discussions on Twitter

Vergleichen Sie VTRS mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VTRS Viatris Inc	9.495	11.32B	14.33B	-3.79B	1.84B	-3.17
ZTS Zoetis Inc	140.81	62.79B	9.39B	2.62B	2.22B	5.81
TAK Takeda Pharmaceutical Co Adr	14.66	47.25B	29.96B	957.25M	4.77B	0.304
HLN Haleon Plc Adr	8.73	39.56B	14.26B	1.98B	2.47B	0.4347
TEVA Teva Pharmaceutical Industries Ltd Adr	18.27	22.11B	16.70B	-157.13M	1.19B	-0.155
UTHR United Therapeutics Corp	428.37	19.84B	2.99B	1.21B	1.13B	25.06

Viatris Inc Stock (VTRS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-06-06	Eingeleitet	Goldman	Neutral
2024-07-19	Fortgesetzt	Jefferies	Buy
2023-10-23	Herabstufung	BofA Securities	Neutral → Underperform
2023-06-23	Herabstufung	Barclays	Equal Weight → Underweight
2023-04-24	Herabstufung	Barclays	Overweight → Equal Weight
2023-02-17	Herabstufung	BMO Capital Markets	Outperform → Market Perform
2023-01-27	Hochstufung	Jefferies	Hold → Buy
2022-11-10	Hochstufung	UBS	Sell → Neutral
2022-11-08	Hochstufung	Piper Sandler	Underweight → Neutral
2022-10-21	Fortgesetzt	Jefferies	Hold
2022-06-14	Eingeleitet	UBS	Sell
2022-05-10	Herabstufung	Piper Sandler	Neutral → Underweight
2022-03-01	Herabstufung	BofA Securities	Buy → Neutral
2022-03-01	Herabstufung	Raymond James	Outperform → Mkt Perform
2021-06-15	Eingeleitet	Citigroup	Neutral
2021-04-07	Fortgesetzt	RBC Capital Mkts	Outperform
2021-03-08	Herabstufung	Goldman	Buy → Neutral
2021-03-02	Herabstufung	JP Morgan	Overweight → Neutral
2021-02-26	Herabstufung	Wolfe Research	Outperform → Peer Perform
2021-01-05	Eingeleitet	Argus	Hold
2020-12-14	Eingeleitet	Bernstein	Mkt Perform

Alle ansehen

Viatris Inc Aktie (VTRS) Neueste Nachrichten

Finanzdaten der Viatris Inc-Aktie (VTRS)

Viatris Inc (VTRS)

Viatris Inc Stock (VTRS) Company Profile

Vergleichen Sie VTRS mit anderen Aktien

Viatris Inc Stock (VTRS) Upgrades & Downgrades

Viatris Inc Aktie (VTRS) Neueste Nachrichten

Viatris: Indore Plant Could Boost 2026 Numbers (NASDAQ:VTRS) - Seeking Alpha

Viatris Nixes Biogen's Extra 1-Year Protection Over MS Drug - Law360

Viatris Inc. (VTRS) Gains FDA Approval for First Generic Iron Sucrose Injection - Insider Monkey

How Viatris’ (VTRS) Removal from the FTSE All-World Index Could Affect Investor Sentiment - simplywall.st

Viatris Inc.(NasdaqGS: VTRS) dropped from FTSE All-World Index - MarketScreener

Street Watch: Is Viatris Inc a defensive stock2025 Technical Patterns & Weekly Stock Performance Updates - خودرو بانک

Fundamentals Check: Is now the right time to enter Viatris IncJuly 2025 Spike Watch & Target Return Focused Picks - khodrobank.com

Trading Recap: Can Viatris Inc. withstand a market correctionInsider Selling & Precise Trade Entry Recommendations - khodrobank.com

Forecast Cut: How do insiders feel about Viatris IncWeekly Stock Report & Long Hold Capital Preservation Tips - خودرو بانک

Short Covering: Will Viatris Inc stock hit new highs in YEAROil Prices & Free Verified High Yield Trade Plans - khodrobank.com

VIX Spike: Can Viatris Inc ride the EV waveRisk Management & Reliable Momentum Entry Alerts - خودرو بانک

Viatris Inc. (VTRS) Enters $515M IV Iron Market With FDA Green Light - MSN

Viatris (VTRS) Recovers Slightly But Struggles Amid Market Conce - GuruFocus

Viatris rises after a steep seven-day slide - MSN

Day 7 of Loss Streak for Viatris Stock with -9% Return (vs. -20% YTD) [9/16/2025] - Trefis

Institution Moves: Can Viatris Inc ride the EV waveLong Setup & Daily Momentum Trading Reports - خودرو بانک

Volatility Watch: Is Viatris Inc stock suitable for long term investing2025 Bull vs Bear & Weekly High Conviction Trade Ideas - خودرو بانک

Market Moves: Is now the right time to enter Viatris IncJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - khodrobank.com

Aug Swings: Is now the right time to enter Viatris IncJuly 2025 Spike Watch & Target Return Focused Picks - khodrobank.com

Market Leaders: Can Viatris Inc. navigate macro headwindsQuarterly Profit Report & Consistent Return Strategy Ideas - خودرو بانک

Viatris chief commercial officer Le Goff sells $72k in stock - Investing.com Nigeria

Viatris chief commercial officer Le Goff sells $72k in stock By Investing.com - Investing.com South Africa

Acute myocardial infarction Market Analysis: Epidemiology Insights, Therapies, Companies, by DelveInsight | Idorsia Pharmaceuticals, Viatris, Recardio, AstraZeneca, Faraday Pharmaceuticals, CeleCor Th - Barchart.com

Real time scanner hits for Viatris Inc. explainedMarket Trend Review & Low Risk Profit Maximizing Plans - Newser

Viatris Investors Face Skeptical Judges on Biosimilars Unit (1) - Bloomberg Law News

US Cystic Fibrosis Therapeutics Market Forecast and Company Analysis Report 2025-2033 Featuring Vertex, Abbvie, Novartis, Gilead Sciences, Viatris, Pfizer, AstraZeneca, and F. Hoffmann-La Roche - Yahoo Finance

Viatris receives FDA warning letter for 11 drugs made at India plant - MSN

Trend analysis for Viatris Inc. this weekTreasury Yields & Stepwise Trade Signal Guides - Newser

Is Viatris Inc. Starting a New UptrendEarnings Summary Report & Reliable Momentum Entry Alerts - beatles.ru

Viatris Inc. Forms Double Bottom Pattern — Eyes on Breakout2025 Market WrapUp & Fast Moving Market Watchlists - beatles.ru

What makes Viatris Inc. stock attractive to long term investorsQuarterly Trade Report & AI Forecasted Stock Moves - beatles.ru

Is Viatris Inc. reversing from oversold territoryPortfolio Performance Summary & Consistent Growth Equity Picks - Newser

Custom strategy builders for tracking Viatris Inc.July 2025 Summary & Free Long-Term Investment Growth Plans - Newser

Stock Analysis | Viatris OutlookA Technical Bear Market with Mixed Fundamentals - AInvest

Candlestick signals on Viatris Inc. stock todayJuly 2025 Final Week & Free Weekly Chart Analysis and Trade Guides - Newser

How volatile is Viatris Inc. stockJuly 2025 Action & Free High Accuracy Swing Entry Alerts - خودرو بانک

Will a bounce in Viatris Inc. offer an exitJuly 2025 Short Interest & Weekly Top Performers Watchlists - Newser

When is the best time to exit Viatris Inc.Weekly Stock Analysis & Verified Chart Pattern Signals - Newser

Generic Drugs Market is expected to reach US$ 942.69 billion - openPR.com

How to escape a deep drawdown in Viatris Inc.Earnings Risk Summary & Smart Swing Trading Alerts - Newser

What high frequency data says about Viatris Inc.2025 Institutional Moves & Detailed Earnings Play Strategies - Newser

How to use a screener to detect Viatris Inc. breakoutsVolume Spike & Expert Curated Trade Setups - Newser

Fda discontinues manufacture of Dymista, nasal spray, 137 ug 50 ug - MarketScreener

How to use Fibonacci retracement on Viatris Inc.2025 Earnings Surprises & Weekly Return Optimization Alerts - Newser

Zacks Investment Ideas feature highlights: Church & Dwight, Eli Lilly and Viatris - sharewise.com

Using economic indicators to assess Viatris Inc. potential2025 Risk Factors & Expert Curated Trade Setups - Newser

Risk adjusted return profile for Viatris Inc. analyzedGold Moves & Verified Momentum Stock Alerts - Newser

Finanzdaten der Viatris Inc-Aktie (VTRS)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie VTRS